| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |